Data Year:

For its 2025 fiscal year, CARDINAL HEALTH INC, listed the following executives on its annual proxy statement to the SEC

Equity
Cash Compensation
Other
Fiscal Year Ended in 2025
Name And Title Total Compensation Pay Rank By Title In Retail & Wholesale industry
Jessica L. Mayer
Chief Legal and Compliance Officer
Total Compensation $4,925,352 View details Pay Rank By Title In Retail & Wholesale industry #2 View more
Stephen M. Mason
Chief Executive Officer, Global Medical Products and Distribution Segment
Total Compensation $4,745,044 View details Pay Rank By Title In Retail & Wholesale industry #132 View more
Jason M. Hollar
Chief Executive Officer
Total Compensation $18,976,195 View details Pay Rank By Title In Retail & Wholesale industry #12 View more
Deborah L. Weitzman
Chief Executive Officer, Pharmaceutical and Specialty Solutions Segment
Total Compensation $5,507,857 View details Pay Rank By Title In Retail & Wholesale industry #115 View more
Aaron E. Alt
Chief Financial Officer
Total Compensation $6,210,035 View details Pay Rank By Title In Retail & Wholesale industry #22 View more

The charts on this page feature a breakdown of the total annual pay for the top executives at CARDINAL HEALTH INC as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. CARDINAL HEALTH INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. CARDINAL HEALTH INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Jessica L. Mayer
Chief Legal and Compliance Officer
Total Cash $1,691,959 Equity $3,202,943 Other $30,450 $4,925,352
Stephen M. Mason
Chief Executive Officer, Global Medical Products and Distribution Segment
Total Cash $1,335,477 Equity $3,357,917 Other $51,650 $4,745,044
Jason M. Hollar
Chief Executive Officer
Total Cash $5,044,071 Equity $13,431,441 Other $500,683 $18,976,195
Deborah L. Weitzman
Chief Executive Officer, Pharmaceutical and Specialty Solutions Segment
Total Cash $1,706,443 Equity $3,771,217 Other $30,197 $5,507,857
Aaron E. Alt
Chief Financial Officer
Total Cash $2,174,426 Equity $3,977,813 Other $57,796 $6,210,035
For its 2025 fiscal year, CARDINAL HEALTH INC, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Jason M. Hollar CEO Pay $18,990,992 Median Employee Pay $72,657 CEO Pay Ratio 261:1
For its 2025 fiscal year, CARDINAL HEALTH INC, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Akhil Johri Total Cash $346,953
Christine A. Mundkur Total Cash $319,953
David C. Evans Total Cash $321,953
Gregory B. Kenny Total Cash $570,011
Michelle M. Brennan Total Cash $319,953
Nancy Killefer Total Cash $339,953
Patricia A. Hemingway Hall Total Cash $341,953
Robert W. Azelby Total Cash $321,953
Robert W. Musslewhite Total Cash $172,491
Sheri H. Edison Total Cash $339,953
Steven K. Barg Total Cash $42,131
Sudhakar Ramakrishna Total Cash $172,491
Sujatha Chandrasekaran Total Cash $42,131
Browse Board of Directors By First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Executives by First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Companies by Company Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

Use of Data / Disclaimer

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

What is a proxy statement?

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.